Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and

Ambiq Announces Pricing of Initial Public Offering Ambiq Announces Pricing of Initial Public Offering AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of

DUBLIN and NOUAKCHOTT, Mauritania, July 29, 2025 (GLOBE NEWSWIRE) — EllaLink, the owner of a high-capacity optic-fibre submarine cable directly connecting Europe and Latin America, and the Ministère de la Transformation Numérique et de la Modernisation de l’Administration (MTNMA) of the Islamic Republic of Mauritania have signed a contract for

DUBLIN and NOUAKCHOTT, Mauritania, July 29, 2025 (GLOBE NEWSWIRE) — EllaLink, the owner of a high-capacity optic-fibre submarine cable directly connecting Europe and Latin America, and the Ministère de la Transformation Numérique et de la Modernisation de l’Administration (MTNMA) of the Islamic Republic of Mauritania have signed a contract for